Merck Sharp Dohme Corp.
Records under this name other than the patents Merck Sharp Dohme Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 8 of 8 · Back to Merck Sharp Dohme Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,557,992 | Heterocyclic Fused Phenanthrolinone M1 Receptor Positive Allosteric Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 7,304,094 | Novel Cyclohexyl Sulphones Term ended Term ended Sep 20, 2022 · High confidence | Term ended | Term ended Sep 20, 2022 | High confidence |
| US 8,518,975 | Gamma Secretase Modulators Lapsed on the fee record Ended Aug 27, 2017 · High confidence | Lapsed on the fee record | Ended Aug 27, 2017 | High confidence |
| US 8,293,731 | HIV Integrase Inhibitors Lapsed on the fee record Ended Oct 23, 2016 · High confidence | Lapsed on the fee record | Ended Oct 23, 2016 | High confidence |
| US 8,222,418 | Piperidines and Related Compounds for the Treatment of Dementia Lapsed on the fee record Ended Jul 17, 2016 · High confidence | Lapsed on the fee record | Ended Jul 17, 2016 | High confidence |
| US 7,300,955 | Method and Materials for Treatment of Alzheimer's Disease Lapsed on the fee record Ended Nov 27, 2015 · High confidence | Lapsed on the fee record | Ended Nov 27, 2015 | High confidence |
| US 5,254,561 | Tricyclic antipsychotic agents Formerly held Term ended Term ended no later than Oct 19, 2013 · Low confidence | Term ended | Term ended no later than Oct 19, 2013 | Low confidence |
| US 5,612,337 | Substituted morpholine derivatives and their use as therapeutic agents Term ended Term ended no later than Mar 18, 2017 · Low confidence | Term ended | Term ended no later than Mar 18, 2017 | Low confidence |